Clinical trial
Revascularization Pretreated With Fingolimod in Acute Stroke
NCT04718064 is registered in ClinicalTrials.gov with The Affiliated Hospital of Xuzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Revascularization Pretreated With Fingolimod in Acute Stroke
- Lead sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 1, 2021
- Completion date
- January 31, 2022
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.